Kateterburen slutning av persisterande foramen ovale. (PFO) [Percutaneuos transcatheter closure of patent foramen ovale]
M Dellborg, P Eriksson, P Ladenvall, N Mirzada, B Runmarker, L Jivegard, A Strandell, T Svanberg, M Eriksson
Citation
M Dellborg, P Eriksson, P Ladenvall, N Mirzada, B Runmarker, L Jivegard, A Strandell, T Svanberg, M Eriksson. Kateterburen slutning av persisterande foramen ovale. (PFO). [Percutaneuos transcatheter closure of patent foramen ovale] Gothenburg: The Regional Health Technology Assessment Centre (HTA-centrum). HTA-rapport 2010:31. 2010
Authors' objectives
Is percutaneous transcatheter closure of patent foramen ovale (PFO) a better method for prevention of a new ischemic stroke/TIA than long-term anticoagulant therapy, for adult patients with PFO that have had a cryptogenic ischemic stroke/TIA?
Authors' conclusions
Cryptogenic strokes are relatively common and may lead to death and considerable morbidity. Present studies with/without control group shows that transcatheter closure of PFO may be conducted with relatively low risk, in the short-term, and suggests that the method reduces the frequency of new stroke/TIA. However, the scientific support is insufficient, as also for assessment of reduced mortality.
The Regional Health Technology Assessment Centre, Region Vastra Gotaland, HTA-centrum, Roda Straket 8, Sahlgrenska Universitetssjukhuset, 413 45 GOTHENBORG, Sweden Email: hta-centrum@vgregion.se
